MedTech commercialization with commercial and operational reality built in
Q22 supports companies that need to turn medical technology, healthcare innovation or device related propositions into market relevant commercial progress.
The focus is on positioning, partner selection, customer access, market access support, operational readiness and practical commercial execution in Europe.
Commercialization support
MedTech commercialization requires more than a strong product. Companies need the right proposition, partners, clinical and operational logic and a credible route to market.
- Commercial strategy for medical devices and healthcare innovations
- Value proposition and stakeholder messaging
- Market access support and reimbursement logic where relevant
- Distributor, CDMO, logistics and service partner selection
- Commercial outreach and strategic partnership development
- Operational execution across the healthcare value chain
Why Q22
Q22 combines hands on experience across MedTech, pharma, biomaterials, medical nutrition and healthcare innovation.
Where commercialization often gets stuck
Many MedTech companies underestimate the difference between a promising product and a scalable commercial route. Q22 helps close that gap with practical senior support.
Market relevance
Translate features and technology into customer value, buying logic and adoption drivers.
Partner structure
Identify the commercial and operational partners needed to make market entry realistic.
Execution rhythm
Turn strategy into outreach, meetings, proposals, partnerships and commercial learning.
Let’s discuss your next move
For questions, introductions or a first discussion, please contact Q22 directly by email.
Q22
Senior commercial thinking, practical execution and access to the right partners across the healthcare value chain.